To include your compound in the COVID-19 Resource Center, submit it here.

Banoxantrone: Phase Ib/IIa started

NOVC started an open-label Phase Ib/IIa trial in 60 patients

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE